19-51491689-T-A
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The NM_053003.4(SIGLEC12):c.1740A>T(p.Glu580Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000155 in 1,613,976 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_053003.4 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SIGLEC12 | ENST00000291707.8 | c.1740A>T | p.Glu580Asp | missense_variant | Exon 8 of 8 | 1 | NM_053003.4 | ENSP00000291707.3 | ||
SIGLEC12 | ENST00000596742.1 | n.*955A>T | non_coding_transcript_exon_variant | Exon 8 of 8 | 1 | ENSP00000469791.1 | ||||
SIGLEC12 | ENST00000596742.1 | n.*955A>T | 3_prime_UTR_variant | Exon 8 of 8 | 1 | ENSP00000469791.1 | ||||
SIGLEC12 | ENST00000598614.1 | c.1386A>T | p.Glu462Asp | missense_variant | Exon 7 of 7 | 5 | ENSP00000472873.1 |
Frequencies
GnomAD3 genomes AF: 0.0000723 AC: 11AN: 152108Hom.: 0 Cov.: 31 show subpopulations
GnomAD2 exomes AF: 0.0000159 AC: 4AN: 251390 AF XY: 0.0000147 show subpopulations
GnomAD4 exome AF: 0.00000958 AC: 14AN: 1461868Hom.: 0 Cov.: 31 AF XY: 0.0000110 AC XY: 8AN XY: 727240 show subpopulations
GnomAD4 genome AF: 0.0000723 AC: 11AN: 152108Hom.: 0 Cov.: 31 AF XY: 0.0000538 AC XY: 4AN XY: 74302 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1740A>T (p.E580D) alteration is located in exon 8 (coding exon 8) of the SIGLEC12 gene. This alteration results from a A to T substitution at nucleotide position 1740, causing the glutamic acid (E) at amino acid position 580 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at